>_ QFI Terminal
Terminal › Stocks › JYNT

The Joint Corp. (JYNT) Stock

Healthcare · Medical - Care Facilities · US
$6.80 -0.44%
Last updated Nov 12, 2026 09:30 UTC

JYNT Key Statistics

Market Cap$96.17M
P/E (TTM)34.00
P/S (TTM)1.64
P/B (TTM)7.78
Revenue (TTM)$58.72M
EPS (TTM)$0.20
Dividend Yield—
ROE (TTM)19.28%
Net Margin4.81%
Gross Margin82.25%
52W High$10.58
52W Low$6.52
Analyst ViewBuy
Price Target$20.00
Employees330
Volume47,917

About The Joint Corp.

The Joint Corp. specializes in the establishment, proprietorship, operation, and overall administration of chiropractic treatment centers. Its business operations are structured into two main divisions: corporate-owned clinics and franchised facilities. The firm employs several strategic models for its expansion and day-to-day functioning, which include direct company ownership, various management agreements, licensing its brand to franchisees, and collaborating with regional development partners. As of March 1, 2022, the company maintained approximately 700 active locations throughout the United States. Founded in 2010, The Joint Corp. maintains its primary corporate headquarters in Scottsdale, Arizona.

CEO: Sanjiv Razdan. Company website

JYNT — Frequently Asked Questions

What is the JYNT stock price today?

The Joint Corp. (JYNT) trades at $6.80, down 0.44% on the day, as of Nov 12, 2026 09:30 UTC.

What is The Joint Corp.'s market cap?

The Joint Corp. has a market capitalisation of $96.17M, calculated from the live JYNT share price and shares outstanding.

What is the P/E ratio of JYNT?

JYNT trades at a trailing P/E of 34.00, from earnings per share of $0.20 over the last twelve months.

How much revenue does The Joint Corp. make?

The Joint Corp. generated revenue of $58.72M over the trailing twelve months, which puts the stock at 1.64 times sales.

What is the 52-week range for JYNT?

JYNT has traded between $6.52 and $10.58 over the past 52 weeks, and the last price is 35.7% below that high.

Is The Joint Corp. profitable?

Yes. The Joint Corp. keeps 4.81% of revenue as net income over the trailing twelve months.

What is the analyst price target for JYNT?

Wall Street analysts rate JYNT Buy, with an average price target of $20.00, 194.1% above the current price.

What sector is The Joint Corp. in?

The Joint Corp. is classified under the Healthcare sector and the Medical - Care Facilities industry, and is domiciled in US.

Who is the CEO of The Joint Corp.?

Sanjiv Razdan is the chief executive of The Joint Corp., which employs 330 people.

Where can I track JYNT in real time?

QFI Terminal shows JYNT with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See JYNT live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open JYNT in Terminal See plans

Medical - Care Facilities stocks

HCA HCA Healthcare, Inc. THC Tenet Healthcare Corporation FMS Fresenius Medical Care AG & Co. KGaA UHS Universal Health Services, Inc. DVA DaVita Inc. CYH Community Health Systems, Inc. EHC Encompass Health Corporation ENSG The Ensign Group, Inc. SEM Select Medical Holdings Corporation ACHC Acadia Healthcare Company, Inc. HIMS Hims & Hers Health, Inc. CHE Chemed Corporation MD Pediatrix Medical Group, Inc. HCSG Healthcare Services Group, Inc. USPH U.S. Physical Therapy, Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc. AZN AstraZeneca PLC NVS Novartis AG SNY Sanofi BMY Bristol-Myers Squibb Company ABT Abbott Laboratories TMO Thermo Fisher Scientific Inc. MOH Molina Healthcare, Inc. AMGN Amgen Inc. MDT Medtronic Plc GSK GSK plc

ETFs holding JYNT

VTI Vanguard Morningstar Total Stock Market ETF 0.00%

Largest institutional holders of JYNT

Bandera Partners LLC 3,937,296 shares
Skylands Capital, LLC 946,045 shares
JCP Investment Management, LLC 593,906 shares
VANGUARD CAPITAL MANAGEMENT LLC 557,053 shares
FIRST FOUNDATION ADVISORS 334,865 shares
BlackRock, Inc. BLK 288,615 shares
JANE STREET GROUP, LLC 235,851 shares
VANGUARD PORTFOLIO MANAGEMENT LLC 224,740 shares
RENAISSANCE TECHNOLOGIES LLC 219,478 shares
DIMENSIONAL FUND ADVISORS LP 157,386 shares

JYNT insiders on other boards

WU The Western Union Company Pant Milind KMB Kimberly-Clark Corporation Karrmann Sandra R